Spyre Therapeutics, Inc. short interest in 2021
In 2021, Spyre Therapeutics, Inc.'s disclosed short interest ran from 4.00% of shares outstanding on 15 Jan 2021 to 1.67% on 31 Dec 2021, a change of -2.33 percentage points. The year's high was 4.58% on 15 Jun 2021 and its low 1.34% on 15 Oct 2021, averaging 2.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.07 days on 15 Apr 2021. Full history: Spyre Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 4.00% (15 Jan 2021)
- End of year
- 1.67% (31 Dec 2021)
- Change
- -2.33 pp
- High
- 4.58% (15 Jun 2021)
- Low
- 1.34% (15 Oct 2021)
- Average
- 2.99%
- Highest days to cover
- 24.07 (15 Apr 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 4.00% | 10.20 | |
| 29 Jan 2021 | 3.88% | 7.30 | |
| 12 Feb 2021 | 3.74% | 9.26 | |
| 26 Feb 2021 | 3.78% | 11.12 | |
| 15 Mar 2021 | 4.20% | 10.27 | |
| 31 Mar 2021 | 4.34% | 8.51 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 4.55% | 24.07 | |
| 30 Apr 2021 | 4.23% | 19.65 | |
| 14 May 2021 | 4.14% | 18.13 | 10-Q filed, results (8-K) |
| 28 May 2021 | 4.39% | 12.11 | |
| 15 Jun 2021 | 4.58% | 10.51 | |
| 30 Jun 2021 | 4.23% | 5.86 | |
| 15 Jul 2021 | 2.94% | 8.66 | |
| 30 Jul 2021 | 2.17% | 11.53 | |
| 13 Aug 2021 | 2.10% | 7.83 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 2.05% | 8.22 | |
| 15 Sep 2021 | 1.60% | 4.58 | |
| 30 Sep 2021 | 1.70% | 5.41 | |
| 15 Oct 2021 | 1.34% | 6.25 | |
| 29 Oct 2021 | 1.40% | 5.46 | |
| 15 Nov 2021 | 1.34% | 5.42 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 1.39% | 3.42 | |
| 15 Dec 2021 | 1.90% | 1.04 | |
| 31 Dec 2021 | 1.67% | 3.26 |
See also: Spyre Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.